Fuan Pharmaceutical (Group) Co., Ltd. (300194.SZ)
CNY 4.11
(2.49%)
CNY 4.11
(2.49%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 5.97 Billion CNY | 1.67% |
| 2022 | 5.87 Billion CNY | 3.01% |
| 2021 | 5.7 Billion CNY | -4.46% |
| 2020 | 5.97 Billion CNY | 26.12% |
| 2019 | 4.73 Billion CNY | 10.33% |
| 2018 | 4.29 Billion CNY | -8.45% |
| 2017 | 4.68 Billion CNY | 6.62% |
| 2016 | 4.39 Billion CNY | 77.39% |
| 2015 | 2.47 Billion CNY | 35.31% |
| 2014 | 1.83 Billion CNY | -1.67% |
| 2013 | 1.86 Billion CNY | 3.25% |
| 2012 | 1.8 Billion CNY | -0.68% |
| 2011 | 1.81 Billion CNY | 424.97% |
| 2010 | 346.13 Million CNY | 26.5% |
| 2009 | 273.62 Million CNY | 35.06% |
| 2008 | 202.58 Million CNY | 150.45% |
| 2007 | 80.88 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 5.99 Billion CNY | -0.36% |
| 2024 Q3 | 6.04 Billion CNY | 0.72% |
| 2024 Q1 | 6.01 Billion CNY | 0.72% |
| 2023 Q1 | 6.29 Billion CNY | 7.1% |
| 2023 Q4 | 5.97 Billion CNY | -3.07% |
| 2023 FY | 5.97 Billion CNY | 1.67% |
| 2023 Q2 | 6.3 Billion CNY | 0.08% |
| 2023 Q3 | 6.16 Billion CNY | -2.14% |
| 2022 Q3 | 5.99 Billion CNY | 2.49% |
| 2022 FY | 5.87 Billion CNY | 3.01% |
| 2022 Q2 | 5.85 Billion CNY | 4.72% |
| 2022 Q4 | 5.87 Billion CNY | -2.03% |
| 2022 Q1 | 5.59 Billion CNY | -2.04% |
| 2021 Q3 | 6.12 Billion CNY | 1.37% |
| 2021 FY | 5.7 Billion CNY | -4.46% |
| 2021 Q1 | 6.11 Billion CNY | 2.41% |
| 2021 Q2 | 6.04 Billion CNY | -1.19% |
| 2021 Q4 | 5.7 Billion CNY | -6.87% |
| 2020 Q3 | 5.87 Billion CNY | 3.51% |
| 2020 Q4 | 5.97 Billion CNY | 1.6% |
| 2020 Q2 | 5.67 Billion CNY | 14.24% |
| 2020 Q1 | 4.97 Billion CNY | 4.97% |
| 2020 FY | 5.97 Billion CNY | 26.12% |
| 2019 Q2 | 4.43 Billion CNY | 2.28% |
| 2019 Q4 | 4.73 Billion CNY | 3.93% |
| 2019 FY | 4.73 Billion CNY | 10.33% |
| 2019 Q3 | 4.55 Billion CNY | 2.68% |
| 2019 Q1 | 4.33 Billion CNY | 1.07% |
| 2018 Q3 | 4.85 Billion CNY | 2.78% |
| 2018 Q1 | 4.81 Billion CNY | 2.76% |
| 2018 FY | 4.29 Billion CNY | -8.45% |
| 2018 Q4 | 4.29 Billion CNY | -11.64% |
| 2018 Q2 | 4.72 Billion CNY | -1.89% |
| 2017 Q3 | 4.6 Billion CNY | 2.01% |
| 2017 Q4 | 4.68 Billion CNY | 1.78% |
| 2017 FY | 4.68 Billion CNY | 6.62% |
| 2017 Q1 | 4.48 Billion CNY | 2.09% |
| 2017 Q2 | 4.51 Billion CNY | 0.59% |
| 2016 Q2 | 3.9 Billion CNY | 56.37% |
| 2016 FY | 4.39 Billion CNY | 77.39% |
| 2016 Q4 | 4.39 Billion CNY | -3.06% |
| 2016 Q3 | 4.53 Billion CNY | 16.17% |
| 2016 Q1 | 2.49 Billion CNY | 0.74% |
| 2015 Q3 | 2.46 Billion CNY | -0.52% |
| 2015 Q4 | 2.47 Billion CNY | 0.65% |
| 2015 FY | 2.47 Billion CNY | 35.31% |
| 2015 Q1 | 1.82 Billion CNY | -0.17% |
| 2015 Q2 | 2.47 Billion CNY | 35.36% |
| 2014 Q4 | 1.83 Billion CNY | -0.09% |
| 2014 Q3 | 1.83 Billion CNY | -1.81% |
| 2014 FY | 1.83 Billion CNY | -1.67% |
| 2014 Q2 | 1.86 Billion CNY | 0.71% |
| 2014 Q1 | 1.85 Billion CNY | -0.48% |
| 2013 Q2 | 1.82 Billion CNY | -1.05% |
| 2013 Q4 | 1.86 Billion CNY | -3.52% |
| 2013 FY | 1.86 Billion CNY | 3.25% |
| 2013 Q1 | 1.84 Billion CNY | 2.1% |
| 2013 Q3 | 1.93 Billion CNY | 5.93% |
| 2012 FY | 1.8 Billion CNY | -0.68% |
| 2012 Q1 | 1.8 Billion CNY | -0.82% |
| 2012 Q4 | 1.8 Billion CNY | -0.24% |
| 2012 Q3 | 1.8 Billion CNY | 0.6% |
| 2012 Q2 | 1.79 Billion CNY | -0.22% |
| 2011 Q1 | 1.69 Billion CNY | 390.4% |
| 2011 FY | 1.81 Billion CNY | 424.97% |
| 2011 Q4 | 1.81 Billion CNY | 5.87% |
| 2011 Q2 | 1.69 Billion CNY | -0.43% |
| 2011 Q3 | 1.71 Billion CNY | 1.56% |
| 2010 Q4 | 346.13 Million CNY | 0.0% |
| 2010 Q2 | 316.99 Million CNY | 0.0% |
| 2010 FY | 346.13 Million CNY | 26.5% |
| 2009 FY | 273.62 Million CNY | 35.06% |
| 2008 FY | 202.58 Million CNY | 150.45% |
| 2007 FY | 80.88 Million CNY | 0.0% |